“Prelude” to Neuromuscular Disease SMA May Offer Chances for Better Treatment

SMA appears to be preceded by abnormalities in embryonic development that have not yet been recognized and could hold approaches for therapy.

What is the situation of early Alzheimer's diagnostics in Germany?

Science and pharma join forces to scrutinize our healthcare system.

Scientists Unravel Life-saving Effect of Dexamethasone in COVID-19

Study in “Cell”.

Blood Markers Detect Rare Forms of Dementia as well as the Neurological Diseases ALS and PSP

Research with data from Germany and Spain opens up new options for diagnosis.

Berlin-Brandenburg Academy of Science Honors Bonn Neurobiologist

Frank Bradke receives the 50,000 Euro Academy Prize.

Secretary of State Pirscher visits DZNE

Among other things, she visited the clinical study unit and the PRECISE laboratories.

Swarm Learning presented at HPE Discover 2024

HPE President & CEO Antonio Neri talks about joint concept by HPE and DZNE.

"The decision is incomprehensible": Statements of DZNE experts on the refusal of "Lecanemab" by European Medicines Agency

European Medicines Agency recommends refusal of marketing authorization of novel Alzheimer’s drug

Reason: benefits of „Lecanemab” do not outweigh the risks.

Grants for Bonn Researchers

Two early-career scientists in Bonn have been awarded grants by the VolkswagenStiftung and the EU Joint Programme – Neurodegenerative Disease Research (JPND).

Topping-out ceremony for new home in Greifswald

Shared use with other research institutes.

Long-term results of Dementia Care Management

Video interview with DZNE scientist Bernhard Michalowsky.

New Insights into the Risk of Heart Attack in Stroke Patients

Study sheds light on the interaction of brain and heart.

New Approach against FTD Tested in Lab Study

Publication in “Science Translational Medicine”.

Joachim Schultze talks in the podcast "KI-Update" by heise online

The Bonn-based researcher discusses the use of swarm learning in medical research - and beyond.